StocksAxogen Inc.AXGN

AXGN

Axogen Inc.

10.00 0.48 (5.04%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
9.98
B
10.03

Overview

Prev Close10.00
Day's Range 9.32 - 10.04
52 Week Range 6.86 - 22.36
Average Volume (3m)345.1K
1-Year Return-52.43%
Beta1.2438
Market Cap419.81M
P/E Ratio
Revenue127.33M
EPS-0.766
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.709/12/202118/02/202203/05/20227.008.009.0010.0011.00
Chart times in UTC
Industry Medical Specialties
CEO Karen L. Zaderej, MBA
Employees 451

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, Axogen Inc.'s revenues decreased by 1.68% and amounted to 31.01M. Net income decreased by 117.08% to -11.48M. Net assets decreased by 7.73% to 103.85M and EPS decreased from -0.13 to -0.27.
AXGN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
81.70%
Net Profit Margin
-22.73%
Operating Margin
-23.97%
Return On Investment
-17.77%
06/21
09/21
12/21
03/22
Total Revenue
33.58M
31.2M
31.54M
31.01M
Gross Profit
26.49M
25.97M
26.11M
25.46M
Operating Income
N/A
-6.69M
-5.35M
-11.32M
Net Income
-7.9M
-7.14M
-5.29M
-11.48M